Suicide risk screening is especially challenging. Although data are not yet available to ascertain how COVID-19 will affect the suicide rate, the 3-tiered clinical pathway has been revised to accommodate mostly telehealth screening.
The US Food and Drug Administration is working diligently to provide the public with information to keep consumers well and safe. From hand sanitizers to testing to food safety, this slideshow presents the latest developments.
Psychiatric Times has collected information to answer your most pressing questions, including how to prepare your office and staff, resources for patients, and information you need to implement telepsychiatry.